Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New principle for developing vaccines

13.12.2007
Infections with a certain type of bacteria (group B streptococcus) can lead to severe, sometimes life-threatening, infections in newborn infants.

In Sweden some 100 children contract these infections each year. Now medical researchers at Lund University are on the track of a possible future vaccine. The method they are using may also be of significance for other new vaccines.

When a new vaccine is developed, it is often done by first selecting a certain protein that characterizes the bacterium or virus the vaccine will be targeting. In the next step a certain part of the protein is singled out that has an especially strong capacity to rouse the body’s immune defense.

The idea of a vaccine is for the immune defense to recognize and react to a future invader. Selected portions of a couple of different proteins are sometimes combined into a so-called fusion protein.

“But we tried another way of thinking. Perhaps the other parts of the protein that don’t provoke the immune defense as much are more important to the protein. They may have been hidden from the immune defense precisely because they are so important,” wonders Gunnar Lindahl, professor of medical microbiology.

A new fusion protein based on this idea turned out to have the very best effect on group B streptococci­just the opposite of the conventional principles.

“This discovery is significant not only for battling streptococci but also for developing new vaccines in general. The conventional way of going about it might not be the most effective,” maintains Gunnar Lindahl.

A vaccine against group B streptococci would probably be given to young women ahead of their first pregnancy. One possibility would be to do this in combination with the vaccine against cervical cancer that was launched earlier this year and targets teenage girls prior to their sexual debut.

The findings are published in Cell Host & Microbe, a new sister journal of the prestigious Cell­.

Ingela Björck | alfa
Further information:
http://www.cellhostandmicrobe.com/

More articles from Health and Medicine:

nachricht New flexible, transparent, wearable biopatch, improves cellular observation, drug delivery
12.11.2018 | Purdue University

nachricht Exosomes 'swarm' to protect against bacteria inhaled through the nose
12.11.2018 | Massachusetts Eye and Ear Infirmary

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

Im Focus: Nanorobots propel through the eye

Scientists developed specially coated nanometer-sized vehicles that can be actively moved through dense tissue like the vitreous of the eye. So far, the transport of nano-vehicles has only been demonstrated in model systems or biological fluids, but not in real tissue. The work was published in the journal Science Advances and constitutes one step further towards nanorobots becoming minimally-invasive tools for precisely delivering medicine to where it is needed.

Researchers of the “Micro, Nano and Molecular Systems” Lab at the Max Planck Institute for Intelligent Systems in Stuttgart, together with an international...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

In focus: Peptides, the “little brothers and sisters” of proteins

12.11.2018 | Life Sciences

Materials scientist creates fabric alternative to batteries for wearable devices

12.11.2018 | Materials Sciences

A two-atom quantum duet

12.11.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>